SCHEMBL19618655

SCHEMBL19618655

COC(=O)NC(C(=O)N1CC=CC1c1nc(-c2ccc(C)cc2)c[nH]1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 2/20 0.43
▸ TACR3 P29371 7/20 0.38
▸ CYP3A4 P08684 7/20 0.37
▸ CYP2C9 P11712 6/20 0.37
▸ CYP2C19 P33261 5/20 0.37
▸ CYP1A2 P05177 3/20 0.37
▸ CYP2D6 P10635 3/20 0.37
▸ PHGDH O43175 1/20 0.33
▸ OPRK1 P41145 1/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ TACR2 P21452 3/20 0.31
▸ TSHR P16473 2/20 0.31
▸ TP53 P04637 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ NFKB1 P19838 1/20 0.31
▸ MTOR P42345 1/20 0.31
▸ BLM P54132 1/20 0.31
▸ PMP22 Q01453 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17751542 0.96 KCNH2 (0.47) KCNH2TACR3CYP3A4CYP2C9CYP2C19
SCHEMBL16282928 0.96 KCNH2 (0.47) KCNH2TACR3CYP3A4CYP2C9CYP2C19
SCHEMBL19620132 0.96 KCNH2 (0.47) KCNH2TACR3CYP3A4CYP2C9CYP2C19
SCHEMBL16282904 0.96 KCNH2 (0.47) KCNH2TACR3CYP3A4CYP2C9CYP2C19
SCHEMBL18727069 0.92 KCNH2 (0.42) KCNH2TACR3CYP3A4CYP2C9CYP2C19
SCHEMBL18727074 0.92 KCNH2 (0.42) KCNH2TACR3CYP3A4CYP2C9CYP2C19
SCHEMBL16282777 0.92 KCNH2 (0.42) KCNH2TACR3CYP3A4CYP2C9CYP2C19
SCHEMBL16282925 0.88 KCNH2 (0.50) KCNH2CYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL17751541 0.88 KCNH2 (0.50) KCNH2CYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL16282902 0.88 KCNH2 (0.50) KCNH2CYP3A4CYP2C9CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9820972-B2 Antiviral compounds highly effective as HCV-NS5A inhibitor AB Pharma Ltd. (CN) 2017-11-21 — — US disclosed
US-9820972-B2 Antiviral compounds highly effective as HCV-NS5A inhibitor AB Pharma Ltd. (CN) 2017-11-21 — — US disclosed
Send feedback